The sources said both deals could receive a green light from the Justice Department within the next few weeks.
To ease anticompetitive concerns, federal regulators will require CVS and Aetna to divest some of their Medicare Part D assets, the people familiar with the matter told WSJ. A potential bidder for the Part D assets is WellCare Health Plans, but conversations between CVS and Aetna are still ongoing, the sources said.
As for the Cigna-Express Scripts deal, people familiar with the transaction said it could gain approval without any divestitures, according to the report.
More articles on payers:
CMS erroneously sends termination letters to 38K+ BCBS Medicare members
Cigna hires global chief data and analytics officer
Medicaid covers 43% of childbirths
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
